Search for: "Barr Laboratories IncĀ " Results 41 - 60 of 166
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
28 Feb 2012, 1:11 pm by Tom Lamb
Bayer 2011 Annual Report: Settlement Agreements: 70 Cases Settled As of Mid-February 2012; Negotiations Will Continue On Case-by-Case Basis (Posted by Tom Lamb at DrugInjuryWatch.com) From February 1, 2011 to February 1, 2012 the number of lawsuits in the U.S. served upon Bayer involving side effects allegedly from the use of Bayer’s oral contraceptive products Yasmin™ and/or YAZ™ or from the use of Ocella™ and/or Gianvi™ has increased from 6,850… [read post]
11 Nov 2011, 2:00 am by Jack Pringle
Cephalon, Inc., Plaintiffs in a putative class action alleging violations of the Sherman Antitrust Act sought to compel discovery of certain communications between Defendant Barr Laboratories, Inc. [read post]
31 Oct 2011, 7:00 am by Joshua Matz
Salazar (the Endangered Species Act), Barr Laboratories v. [read post]
28 Oct 2011, 7:38 pm by Kiera Flynn
Petitioners’ reply Amicus brief of International Municipal Lawyers Association   Barr Laboratories, Inc. v. [read post]
10 Oct 2011, 10:00 am by Lucas A. Ferrara, Esq.
Teva, Ranbaxy Pharmaceuticals, Inc., Mylan Pharmaceutical Inc., and Barr Laboratories, Inc. - which Teva now owns - all have taken steps toward entering the market, and all are eligible to seek a 180-day marketing exclusivity provided under federal law. [read post]
9 Sep 2011, 8:30 am by Phil
Barr Laboratories Inc, a unit of Teva, and Novartis (NOVN.VX) (NVS.N) unit Sandoz filed abbreviated new drug applications (ANDA) in 2009 to make a generic version of the drug. [read post]
  The AstraZeneca settlement follows settlements by other defendants to the lawsuit, including Teva Pharmaceuticals, Barr Laboratories, Inc., and Sandoz, Inc. [read post]
27 Aug 2011, 7:55 pm
Barr Labs., Inc., 575 F.3d 1341, 1350 (Fed. [read post]
3 Aug 2011, 9:55 pm by Patent Docs
By Donald Zuhn -- Yesterday, the Federal Circuit affirmed a decision by the District Court for the Southern District of New York finding that Defendants-Appellants Barr Laboratories, Inc. and Pliva-Hrvatska d.o.o. [read post]
28 Jun 2011, 5:03 pm
Barr Labs., 40 F.3d 1223, 1228 (Fed. [read post]
29 Apr 2011, 1:03 pm
Barr Labs., Inc., 251 F.3d 955, 963 (Fed. [read post]
26 Apr 2011, 11:15 pm
Barr Pharmaceutical manufactured Claravis, which contains the same active agent as Accutane (isotretinoin). [read post]
25 Mar 2011, 8:29 pm
Barr Labs., Inc., 251 F.3d 955, 962 (Fed. [read post]